Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZX-7101A in Pediatric Participants With Influenza
NCT07095257Phase 3Completed
- Sponsor
- Zenshine Pharmaceuticals Co., Ltd.
- Start
- Oct 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Seloxavir marboxil in influenza, sponsored by Zenshine Pharmaceuticals Co., Ltd.. Started Oct 2025; status: completed.
02
Drugs
Seloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07095257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07095257.